These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 13780453)
1. Psychological effects of isocarboxazid and nialamide on a group of depressed patients. VASSILIOU V; HIMWICH HE J Clin Psychol; 1961 Jul; 17():319-20. PubMed ID: 13780453 [No Abstract] [Full Text] [Related]
2. An evaluation of the effectiveness of isocarboxazid (Marplan) in the depressive syndromes. ROTHMAN T; GRAYSON H; FERGUSON J Compr Psychiatry; 1961 Feb; 2():27-34. PubMed ID: 13743896 [No Abstract] [Full Text] [Related]
3. An objective assessment of the effects of nialamide on depressed patients. INGLIS J; CAIRD WK; SLOANE RB Can Med Assoc J; 1961 May; 84(19):1059-63. PubMed ID: 13717702 [No Abstract] [Full Text] [Related]
4. [ON THE MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS]. HORNYKIEWICZ O Wien Klin Wochenschr; 1964 Apr; 76():289-93. PubMed ID: 14223504 [No Abstract] [Full Text] [Related]
5. [First results with a new iproniazid derivative, Ro 5-0831 (marplan), in depressive syndromes]. FOURNIAL P; DEMAY-LAULAN M; DEMAY J; ABRAHAM A; ROUDIERE JJ; GOASGUEN J; SCHOCRON G Ann Med Psychol (Paris); 1960 Feb; 118(1)():337-43. PubMed ID: 13824170 [No Abstract] [Full Text] [Related]
6. Variable action of monoamine oxidase-inhibiting hydrazines on serotonin metabolism. KIRBERGER E Nature; 1963 Mar; 197():1211-2. PubMed ID: 14032954 [No Abstract] [Full Text] [Related]
7. Differentiation of two genetically specific types of depression by the response to anti-depressants. PARE CM; REES L; SAINSBURY MJ Lancet; 1962 Dec; 2(7270):1340-3. PubMed ID: 13941389 [No Abstract] [Full Text] [Related]
8. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. II. 5-Hydroxytryptamine tolerance before and after Nialamide. DEWHURST WG; PARE CM J Ment Sci; 1961 Mar; 107():244-9. PubMed ID: 13722404 [No Abstract] [Full Text] [Related]
9. [The use of nialamide in some depression states]. ROSA J Dia Med; 1961 Feb; 33():131-2. PubMed ID: 13743226 [No Abstract] [Full Text] [Related]
10. A clinical and biochemical study of monoamine oxidase inhibition in depressed patients. I. A clinical trial of Nialamide. DEWHURST WG; PARE CM J Ment Sci; 1961 Mar; 107():239-43. PubMed ID: 13722403 [No Abstract] [Full Text] [Related]
11. [Efficacy of nialamide in states of depression]. GUILLERM H; DAVOST PH; GRANDMONTAGE O; PRUD'HOMME B Ann Med Psychol (Paris); 1960 May; 118(1)():972-8. PubMed ID: 13830184 [No Abstract] [Full Text] [Related]
12. Effect of nialamide alone and in combination in treatment of depression. PARKER S Dis Nerv Syst; 1959 Dec; 20():591-3. PubMed ID: 14430509 [No Abstract] [Full Text] [Related]
13. [THE EFFECT OF ANTIDEPRESSIVE AGENTS OF THE HYDRAZINE TYPE ON CARBOHYDRATE METABOLISM IN DEPRESSIVE PATIENTS]. VAN PRAAGH ; LEIJNSE B Ned Tijdschr Geneeskd; 1964 Oct; 108():1935-40. PubMed ID: 14224205 [No Abstract] [Full Text] [Related]
15. Efficacy and safety of nialamide in the treatment of depressive syndromes. KRAKOWSKI AJ Dis Nerv Syst; 1961 Mar; 22():167-71. PubMed ID: 13753904 [No Abstract] [Full Text] [Related]
16. CPT and VCRT performances as functions of imipramine and nialamide. PISHKIN V J Clin Psychol; 1962 Jan; 18():83-6. PubMed ID: 14486949 [No Abstract] [Full Text] [Related]
17. The antagonism of hydrazine-type inhibitors of monoamine oxidase by sodium pyruvate. HORITA A; MATSUMOTO C Life Sci (1962); 1962 Oct; 1():491-501. PubMed ID: 13954904 [No Abstract] [Full Text] [Related]
18. [Nialamide in the treatment of schizophrenic depression and of dipsomania]. OROZCO W Rev Asoc Medica Mex; 1960 Mar; 40():132-41. PubMed ID: 14429109 [No Abstract] [Full Text] [Related]
19. [Use and indications of an antidepressant P 1133, nialamide (Niamide)]. BERTRAND V; BENOIT JC; DAVID A Ann Med Psychol (Paris); 1961 Jul; 119(2)():333-7. PubMed ID: 13868525 [No Abstract] [Full Text] [Related]